Literature DB >> 25199782

Clinical and molecular epidemiology of Escherichia coli sequence type 131 among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli.

Jennifer H Han1, Brian Johnston2, Irving Nachamkin3, Pam Tolomeo4, Warren B Bilker5, Xiangqun Mao4, Connie Clabots2, Ebbing Lautenbach6, James R Johnson2.   

Abstract

This study examined molecular and epidemiologic factors associated with Escherichia coli sequence type 131 (ST131) among hospitalized patients colonized intestinally with fluoroquinolone (FQ)-resistant E. coli between 2002 and 2004. Among 86 patients, 21 (24%) were colonized with ST131. The proportion of ST131 isolates among colonizing isolates increased significantly over time, from 8% in 2002 to 50% in 2004 (P = 0.003). Furthermore, all 19 clonally related isolates were ST131. Future studies should identify potential transmissibility differences between ST131 and non-ST131 strains.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25199782      PMCID: PMC4249391          DOI: 10.1128/AAC.03256-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

2.  Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli.

Authors:  D G White; J D Goldman; B Demple; S B Levy
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

3.  Epidemiological interpretation of chromosomal macro-restriction fragment patterns analyzed by pulsed-field gel electrophoresis.

Authors:  R V Goering; F C Tenover
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

4.  The impact of confounder selection criteria on effect estimation.

Authors:  R M Mickey; S Greenland
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

5.  Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.

Authors:  Ebbing Lautenbach; Neil O Fishman; Joshua P Metlay; Xiangqun Mao; Warren B Bilker; Pam Tolomeo; Irving Nachamkin
Journal:  J Infect Dis       Date:  2006-05-31       Impact factor: 5.226

6.  Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance.

Authors:  Ebbing Lautenbach; Joshua P Metlay; Mark G Weiner; Warren B Bilker; Pam Tolomeo; Xiangqun Mao; Irving Nachamkin; Neil O Fishman
Journal:  Infect Control Hosp Epidemiol       Date:  2009-01       Impact factor: 3.254

7.  Enhanced persistence in the colonic microbiota of Escherichia coli strains belonging to phylogenetic group B2: role of virulence factors and adherence to colonic cells.

Authors:  Forough L Nowrouzian; Ingegerd Adlerberth; Agnes E Wold
Journal:  Microbes Infect       Date:  2006-01-13       Impact factor: 2.700

8.  Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004.

Authors:  James R Johnson; Megan Menard; Brian Johnston; Michael A Kuskowski; Kim Nichol; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

9.  The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup.

Authors:  Olivier Clermont; Marie Lavollay; Sophie Vimont; Catherine Deschamps; Christiane Forestier; Catherine Branger; Erick Denamur; Guillaume Arlet
Journal:  J Antimicrob Chemother       Date:  2008-03-11       Impact factor: 5.790

10.  The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.

Authors:  Lance B Price; James R Johnson; Maliha Aziz; Connie Clabots; Brian Johnston; Veronika Tchesnokova; Lora Nordstrom; Maria Billig; Sujay Chattopadhyay; Marc Stegger; Paal S Andersen; Talima Pearson; Kim Riddell; Peggy Rogers; Delia Scholes; Barbara Kahl; Paul Keim; Evgeni V Sokurenko
Journal:  mBio       Date:  2013-12-17       Impact factor: 7.867

View more
  5 in total

1.  Gut Colonization of Healthy Children and Their Mothers With Pathogenic Ciprofloxacin-Resistant Escherichia coli.

Authors:  Emily A Gurnee; I Malick Ndao; James R Johnson; Brian D Johnston; Mark D Gonzalez; Carey-Ann D Burnham; Carla M Hall-Moore; Jessica E McGhee; Alexander Mellmann; Barbara B Warner; Phillip I Tarr
Journal:  J Infect Dis       Date:  2015-05-12       Impact factor: 5.226

2.  Intestinal Persistence of Colonizing Escherichia coli Strains, Especially ST131-H30, in Relation to Bacterial and Host Factors.

Authors:  James R Johnson; Connie Clabots; Stephen B Porter; Tricia Bender; Brian D Johnston; Paul Thuras
Journal:  J Infect Dis       Date:  2022-06-15       Impact factor: 7.759

3.  Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.

Authors:  David van Duin; Cesar A Arias; Lauren Komarow; Liang Chen; Blake M Hanson; Gregory Weston; Eric Cober; Omai B Garner; Jesse T Jacob; Michael J Satlin; Bettina C Fries; Julia Garcia-Diaz; Yohei Doi; Sorabh Dhar; Keith S Kaye; Michelle Earley; Andrea M Hujer; Kristine M Hujer; T Nicholas Domitrovic; William C Shropshire; An Dinh; Claudia Manca; Courtney L Luterbach; Minggui Wang; David L Paterson; Ritu Banerjee; Robin Patel; Scott Evans; Carol Hill; Rebekka Arias; Henry F Chambers; Vance G Fowler; Barry N Kreiswirth; Robert A Bonomo
Journal:  Lancet Infect Dis       Date:  2020-03-06       Impact factor: 25.071

Review 4.  Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis.

Authors:  M J D Dautzenberg; M R Haverkate; M J M Bonten; M C J Bootsma
Journal:  BMJ Open       Date:  2016-03-17       Impact factor: 2.692

5.  Regional variations in fluoroquinolone non-susceptibility among Escherichia coli bloodstream infections within the Veterans Healthcare Administration.

Authors:  Daniel J Livorsi; Michihiko Goto; Margaret Carrel; Makoto M Jones; Jennifer McDanel; Rajeshwari Nair; Bruce Alexander; Brice Beck; Kelly K Richardson; Eli N Perencevich
Journal:  Antimicrob Resist Infect Control       Date:  2016-10-19       Impact factor: 4.887

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.